GeneBioTech Co. Ltd (086060) — Cash Flow Reinvestment Rate
GeneBioTech Co. Ltd (086060) has a Cash Flow Reinvestment Rate of 1.83x as of December 2025, reinvesting ₩3.93 Billion (capex ₩96.62 Million plus investments ₩-3.83 Billion) from operating cash flow of ₩2.15 Billion. See GeneBioTech Co. Ltd (086060) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
GeneBioTech Co. Ltd Cash Flow Reinvestment Rate (2009–2025)
Historical reinvestment intensity for GeneBioTech Co. Ltd across 12 annual periods. For the full cash flow conversion analysis, see 086060 cash flow metrics.
Annual Cash Flow Reinvestment Rate for GeneBioTech Co. Ltd (2009–2025)
Year-by-year capital reinvestment analysis for GeneBioTech Co. Ltd. See 086060 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.98x | ₩7.49 Billion | ₩7.61 Billion | ₩3.76 Billion | ▲ +19.0% |
| 2023 | 0.83x | ₩6.09 Billion | ₩7.37 Billion | ₩766.93 Million | ▼ -73.0% |
| 2020 | 3.06x | ₩7.63 Billion | ₩2.49 Billion | ₩4.39 Billion | ▲ +216.7% |
| 2018 | 0.97x | ₩5.76 Billion | ₩5.96 Billion | ₩558.47 Million | ▼ -80.2% |
| 2017 | 4.89x | ₩5.54 Billion | ₩1.13 Billion | ₩1.11 Billion | ▲ +1014.3% |
| 2016 | 0.44x | ₩2.33 Billion | ₩5.31 Billion | ₩1.30 Billion | ▲ +3.9% |
| 2015 | 0.42x | ₩1.10 Billion | ₩2.61 Billion | ₩927.06 Million | ▲ +61.1% |
| 2014 | 0.26x | ₩565.10 Million | ₩2.15 Billion | ₩510.55 Million | ▲ +7.2% |
| 2013 | 0.24x | ₩582.01 Million | ₩2.38 Billion | ₩582.01 Million | ▼ -75.4% |
| 2011 | 0.99x | ₩2.51 Billion | ₩2.53 Billion | ₩2.51 Billion | ▲ +66.9% |
| 2010 | 0.60x | ₩693.45 Million | ₩1.17 Billion | ₩693.45 Million | ▲ +593.8% |
| 2009 | 0.09x | ₩229.99 Million | ₩2.68 Billion | ₩229.99 Million | — |